Journal of Oral Health and Community Dentistry

Register      Login

VOLUME 15 , ISSUE 2 ( May-August, 2021 ) > List of Articles


Pandemic COVID-19 and Its Implications in Dentistry: Overt Actions to Deal with Covert Threat

Sumit Munjal, Seema Munjal

Keywords : COVID-19 pandemic, Dentistry in COVID-19, Management, Viral infection and dentist

Citation Information : Munjal S, Munjal S. Pandemic COVID-19 and Its Implications in Dentistry: Overt Actions to Deal with Covert Threat. J Oral Health Comm Dent 2021; 15 (2):92-97.

DOI: 10.5005/jp-journals-10062-0102

License: CC BY-NC 4.0

Published Online: 26-10-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Background: Currently, transmission routes are still to be determined, but common ones include direct transmission (cough, sneeze, and droplet inhalation transmission) and contact transmission (contact with oral, nasal, and eye mucous membranes). Due to the characteristics of dental settings, the risk of cross infections may be high between dental practitioners and patients. Aims and objectives: This review aimed at presenting a recent update on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19) with regards to prevention and control. In the unlikely event of providing dental care to suspected or confirmed cases of the new pandemic, dentists must be cognizant of dire precautions. Materials and methods: A thorough literature search was carried out electronically between 2019 and 2020 present using appropriate keywords. The results were reviewed and prioritized, and the findings were compiled. Out of a total of 94 publications strategically obtained, 23 studies were included in the end for review. Results: Patients are managed according to the severity of the virulence, and all the possible drug trials have been instigated. The menace being new, the limitations of the study do exist. Vaccines are the most effective strategy since they are more cost-effective than the treatment. Conclusion: Identifying a suspected case of COVID-19 is the only way out to mitigate the spread of this novel infection in dental institutions. Clinical significance: Dental health-care providers ought to keep updated in all respects as we are among the healthcare workers bearing the brunt of the situation.

  1. Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis 1995;1(1):7–15. DOI: 10.3201/eid0101.950102.
  2. Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious disease. Nature 2008;451(7181):990–993. DOI: 10.1038/nature06536.
  3. Sohrabi C, Alsafi Z, O' Neill N, et al. World Health Organisation declares emergency: a review of the 2019 novel coronavirus (covid 19). Int J Surg 2020;76:71–76. DOI: 10.1016/j.ijsu.2020.02.034.
  4. Yu F, Du L, Ojcius DM, et al. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect 2020;22(2): 74–79. DOI: 10.1016/j.micinf.2020.01.003.
  5. Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am 2019;33(4):869–889. DOI: 10.1016/j.idc.2019.07.001.
  6. Holmes KV. SARS-associated coronavirus. N Engl J Med 2003;348: 1948–1951. DOI: 10.1056/NEJMp030078.
  7. Falsey AR, Walsh EE. Novel coronavirus and severe acute respiratory syndrome. Lancet 2003;361(9366):1312–1313. DOI: 10.1016/S0140-6736(03)13084-X.
  8. Peng X, Xu X, Li Y, et al. Transmission routes of 2019-nCoV and controls in dental practice Int J Oral Sci 2020;12(1):9. DOI: 10.1038/s41368-020-0075-9.
  9. Liberati A, Altman DG, Telzlaff J, et al. The PRISMA statement for reporting systemic reviews and meta-analysis of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009;339:b2700. DOI: 10.1136/bmj.b2700.
  10. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China 2019. N Engl J Med 2020;382(8):727–733. DOI: 10.1056/NEJMoa2001017.
  11. Tellier R, Li Y, Cowling BJ, et al. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis 2019;19:101. DOI: 10.1186/s12879-019-3707-y.
  12. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-n Cov infection from an asymptomatic contact in Germany. N Engl J Med 2020;382(10):970–971. DOI: 10.1056/NEJMc2001468.
  13. Sabino-Silva R, Jardin ACG, Siqueira WL. Coronavirus COVID-19 impacts to and potential salivary diagnosis. Clin Oral Investig 2020;24(4):1619–1621. DOI: 10.1007/s00784-020-03248-x.
  14. Zuanazzi D, Arts EJ, Jorge PK, et al. Postnatal identification of Zika virus peptides from saliva. J Dent Res 2017;96(10):1078–1084. DOI: 10.1177/0022034517723325.
  15. Cheng ZJ, Shan J. 2019 novel coronavirus: where we are and what we know. Infection 2020;48(2):155–163. DOI: 10.1007/s15010-020-01401-y.
  16. Cortegiani A, Ingoglia G, Ippolito M, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care DOI: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10. PMID: 32173110; PMCID: PMC7270792.
  17. Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol 2020;214:108393. DOI: 10.1016/j.clim.2020.108393.
  18. Furuta Y, Komeno T, Nakamura T. Favipiravir (T-705), a broad-spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 2017;93(7):449–463. DOI: 10.2183/pjab.93.027.
  19. Gralinski LE, Baric RS. Molecular pathology of emerging coronavirus infections. J Pathol 2015;235(2):185–195. DOI: 10.1002/path.4454.
  20. Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res 2020;7(1):11. DOI: 10.1186/s40779-020-00240-0.
  21. Rhodes A, Evans Le, Ahazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Intensive Care Med 2017;43(3):304–377. DOI: 10.1007/s00134-017-4683-6.
  22. Sun P, Lu X, Xu C, et al. Understanding of COVID-19 based on current evidence. J Med Virol 2020;92(6):548–551. DOI: 10.1002/jmv.25722.
  23. Ahn DG, Shin HJ, Kim MH, et al. Current status of epidemiology, diagnosis, therapeutics and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 2020;30(3):313–324. DOI: 10.4014/jmb.2003.03011.
  24. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet 2020;395(10231):1225–1228. DOI: 10.1016/S0140-6736(20)30627-9.
  25. COVID 19-Indian council of medical research/Government of India. Available from: [Accessed April 17, 2020].
  26. Jimenez-Cauhe J, Ortega-Quijano D, de Perosanz-Lobo D, et al. Enanthem in patients with COVID-19 and skin rash. JAMA Dermatol 2020;156(10):1134–1136. DOI: 10.1001/jamadermatol.2020.2550.
  27. Drago F, Paolino S, Rebora A, et al. The challenge of diagnosing atypical exanthems: a clinico-laboratory study. J Am Acad Dermatol 2012;67(6):1282–1288. DOI: 10.1016/j.jaad.2012.04.014.
  28. Government of India/Aarogya setu mobile app. Available from: [Accessed May 25, 2020].
  29. Varshney M, Parel JT, Raizada N, et al. Initial psychological impact of COVID-19 and its correlates in Indian Community: an online (FEEL-COVID) survey. PLoS One 2020;15(5):e0233874. DOI: 10.1371/journal.pone.0233874.
  30. Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140–146. DOI: 10.15585/mmwr.mm6905e1. Erratum in: MMWR Morb Mortal Wkly Rep. 2020 Feb 14;69(6):173. PMID: 32027631; PMCID: PMC7004396.
  31. World Health Organization. Water, sanitation, hygiene, and waste management for the COVID-19 virus: interim guidance. July 29, 2020. Available from:
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.